Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
Standardized Patient-Centered Medication Review in Home Hospice
NCT03972163 · View on ClinicalTrials.gov ↗
Study Summary
This is a pilot cluster randomized trial that tests the effect of a novel intervention that trains hospice staff to 1. regularly review, simplify, and align patients' prescribed medications with their goals of care as their illness progresses, and 2. support family caregivers with education that empowers them to understand each medication's use, develop skills for safe administration, and 3. understand when stopping medications may be beneficial.
Conditions Studied
Interventions
- BEHAVIORAL NIA Medication Management - Active Comparator
- BEHAVIORAL STOPPFrail (Screening Tool of Older Persons Prescriptions)
- BEHAVIORAL "Discontinuing Medication Appropriately" and "Understanding the Art of Communication about Deprescribing"
- BEHAVIORAL "Key Approaches to Support Informal Family Caregivers in Managing Medications"
Study Locations (1)
Massachusetts
- Care Dimensions — Danvers
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2020-01-15 |
| Est. Completion | 2023-12-31 |
| Phase | NA |
Interested in This Trial?
Always speak with your doctor before enrolling in a clinical trial.
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03972163
The ClinicalTrials.gov registry entry for NCT03972163 describes a study currently listed as completed. It is categorized as NA, which is the standard way researchers label where a study sits along the investigational pathway from early safety work through later efficacy and post-marketing evaluation. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Massachusetts, Worcester, which has 200 total studies on file at ClinicalTrials.gov, and sponsors are the parties responsible for study design, oversight, and regulatory filings.
The record links to 7 conditions, with Palliative Care appearing as the primary indexed condition, and to 4 interventions — of which NIA Medication Management - Active Comparator is the first listed. Interventions can include drugs, devices, procedures, behavioral programs, or observational arms, and each is tracked as a separate registry field so that downstream queries can filter accurately. When a trial lists multiple interventions, it usually reflects a multi-arm design or a comparison protocol rather than a single treatment being tested in isolation. The brief summary published in the registry is the clearest source of protocol intent and should be read before drawing conclusions from any sidebar tags.
Geographic footprint matters for practical reasons: NCT03972163 reports 1 study location spanning 1 distinct geographic area — top geographies include Massachusetts. A larger site network tends to correlate with broader recruitment capacity, but it does not imply anything about study quality, and site-level enrollment status can diverge from the overall registry status shown above. Every data point on this page comes from the public ClinicalTrials.gov dataset and is reproduced here for reference only; it is not a medical recommendation, an endorsement of the sponsor, or an invitation to enroll. Verify current status, eligibility criteria, and contact details directly at ClinicalTrials.gov, and discuss any participation decision with your own healthcare provider.
Frequently Asked Questions
What is clinical trial NCT03972163 about?
NCT03972163 is a clinical study titled "Standardized Patient-Centered Medication Review in Home Hospice". This is a pilot cluster randomized trial that tests the effect of a novel intervention that trains hospice staff to 1. regularly review, simplify, and align patients' prescribed medications with their goals of care as their illness progresses, and 2. support family caregivers with education that emp...
What is the current status of trial NCT03972163?
This trial is currently completed. It is a NA study. The enrollment target is 23 participants. The study started on 2020-01-15. Estimated completion is 2023-12-31.
What conditions does trial NCT03972163 study?
This clinical trial studies the following conditions: Palliative Care, Caregivers, Poly Pharmacy, Interdisciplinary Communication, Hospices. These conditions were identified from the trial registry and reflect the primary focus areas of the research.
What interventions are being tested in trial NCT03972163?
The interventions under investigation include: NIA Medication Management - Active Comparator (BEHAVIORAL), STOPPFrail (Screening Tool of Older Persons Prescriptions) (BEHAVIORAL), "Discontinuing Medication Appropriately" and "Understanding the Art of Communication about Deprescribing" (BEHAVIORAL), "Key Approaches to Support Informal Family Caregivers in Managing Medications" (BEHAVIORAL). Each intervention is being evaluated for safety and efficacy as part of this clinical study.
Who is sponsoring clinical trial NCT03972163?
This trial is sponsored by University of Massachusetts, Worcester, which has 200 total clinical trials registered on ClinicalTrials.gov. The sponsor is responsible for the study's design, funding, and regulatory compliance.
Where is trial NCT03972163 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How Clinical Trials Work
Understand phases 1-4, trial design, randomization, and the informed consent process.
Patient Rights in Clinical Trials
Your rights as a participant: consent, withdrawal, privacy, and who to contact.
Finding the Right Clinical Trial
A practical guide to searching trials, understanding eligibility, and evaluating options.
All Guides
Browse our complete library of clinical trial educational resources.
Read our methodology — how this data is sourced, computed, and verified.